Rutgers Cancer Institute of New Jersey,201 Lyons Avenue — Newark, New Jersey

Rutgers Cancer Institute of New Jersey,201 Lyons Avenue is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute of New Jersey,201 Lyons Avenue has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive.

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in New Jersey · View every site in Newark

• Rutgers, State University of New Jersey
• University of Medicine and Dentistry
• Children's Hospital of New Jersey
• University Hospital, Rutgers New Jersey Medical School
• Rutgers University
• University Behavioral HealthCare (UBHC) Extended Treatment Division - Adult Outpatient Psychiatric Services
• University of Medicine & Dentistry of NJ
• Children's Hospital of New Jersey at Newark Beth Israel Medical Center
• University Hospital/New Jersey Cancer Center
• University Hospital UMDNJ
• Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue
• University of Medicine and Dentistry of New Jersey - MOBILE

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute of New Jersey,201 Lyons Avenue?

Rutgers Cancer Institute of New Jersey,201 Lyons Avenue has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute of New Jersey,201 Lyons Avenue conducted?

Rutgers Cancer Institute of New Jersey,201 Lyons Avenue has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive.

Is Rutgers Cancer Institute of New Jersey,201 Lyons Avenue accredited by Crixeo Clinical Trials?

Rutgers Cancer Institute of New Jersey,201 Lyons Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer Institute of New Jersey,201 Lyons Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.